Huayu Yang Selected Research

Huayu Yang Research Topics

Disease

29	Neoplasms (Cancer) 11/2023 - 07/2011
26	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 11/2009
6	Fibrosis (Cirrhosis) 01/2020 - 12/2010
5	Liver Diseases (Liver Disease) 11/2022 - 01/2016
5	Inflammation (Inflammations) 01/2022 - 08/2011
5	Liver Failure 01/2021 - 04/2015
4	Liver Neoplasms (Liver Cancer) 03/2024 - 12/2010
4	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2011
4	Hepatitis 01/2020 - 01/2016
3	Carcinogenesis 03/2024 - 09/2010
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
2	Body Weight (Weight, Body) 01/2023 - 01/2019
2	Fatigue 01/2023 - 08/2020
2	Thrombosis (Thrombus) 12/2022 - 06/2012
2	Fatty Liver 01/2020 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 09/2013
2	Pathologic Processes 10/2019 - 03/2015
2	Hepatitis B 04/2016 - 04/2015
1	Vascular Calcification 12/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023
1	Portal Hypertension 07/2023
1	Flatulence 03/2023
1	COVID-19 01/2023
1	Frailty 01/2023
1	Infections 01/2023
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022
1	Necrosis 01/2022
1	Blister (Bulla) 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Exanthema (Rash) 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021
1	Jaundice (Icterus) 01/2021
1	Lymphatic Metastasis 10/2020
1	Weight Loss (Weight Reduction) 10/2020
1	Hypertrophy 09/2020
1	Hypertension (High Blood Pressure) 08/2020
1	Carcinoma (Carcinomatosis) 08/2020
1	Weight Gain 01/2020

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
8	Proteins (Proteins, Gene)FDA Link 03/2021 - 12/2010
5	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 09/2010
4	AntigensIBA 04/2021 - 10/2020
4	AlbuminsIBA 01/2021 - 01/2016
3	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
3	CarbohydratesIBA 04/2021 - 10/2020
3	Fetal Proteins (Fetoprotein)IBA 04/2016 - 06/2012
2	Biocompatible Materials (Biomaterials)IBA 06/2023 - 01/2020
2	lenvatinibIBA 01/2023 - 08/2020
2	baysilon (polydimethylsiloxane)IBA 01/2022 - 11/2020
2	Monoclonal AntibodiesIBA 01/2022 - 09/2015
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 04/2016
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2020
2	EnzymesIBA 01/2020 - 01/2016
2	LigandsIBA 01/2019 - 01/2019
2	Cell-Free Nucleic AcidsIBA 06/2016 - 04/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024
1	TensinsIBA 03/2024
1	Contrast MediaIBA 07/2023
1	Tenofovir (Viread)FDA Link 02/2023
1	entecavir FDA Link 02/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	regorafenibIBA 01/2023
1	cabozantinibIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	Sunitinib (Sutent)FDA Link 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	sintilimabIBA 01/2022
1	CalciumIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	LipidsIBA 10/2020
1	Lipoproteins (Lipoprotein)IBA 10/2020
1	ApolipoproteinsIBA 10/2020
1	pembrolizumabIBA 08/2020
1	Transaminases (Aminotransferases)IBA 08/2020
1	AlginatesIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020

Therapy/Procedure

13	Hepatectomy 01/2022 - 11/2009
11	Therapeutics 08/2023 - 02/2013
3	Immunotherapy 01/2022 - 01/2020
2	Renal Dialysis (Hemodialysis) 12/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 11/2023 - 02/2013
2	Length of Stay 03/2023 - 04/2021
2	Liver Transplantation 12/2022 - 06/2015
2	Transplantation 01/2021 - 01/2021
2	Ligation 09/2020 - 12/2019
1	Microbubbles 07/2023
1	Operative Surgical Procedures 03/2023
1	Tai Ji (Tai Chi Chuan) 01/2023
1	Perioperative Period 11/2022
1	Precision Medicine 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2020